ClinicalTrials.gg
Not yet recruitingNCT07404124ANKLE-DMUpdated Feb 11, 2026

Effects of Ankle Block on Postoperative Analgesia in Diabetic and Non-Diabetic Patients

An interventional study of Ultrasound-Guided Ankle Block in Diabetes Mellitus, Diabetic Neuropathy and Postoperative Pain Management, sponsored by Fatih Sultan Mehmet Training and Research Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-11.

Primary conditionDiabetic NeuropathiesRegistry: Diabetes MellitusReclassifiedWhy we changed it
Registry
Diabetes Mellitus — the first condition term the registry derived for this study.
ClinicalTrials.gg
Diabetic Neuropathies
Why
  1. The study's listed conditions name Diabetic Neuropathies, a narrower term within Diabetes Mellitus.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Fatih Sultan Mehmet Training and Research Hospital · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Diabetic Neuropathies with a site in Turkey — 6 open to participants now, 7 under way, none of them phase 3. Diabetic Neuropathies · Turkey.

Planned enrollment
12th of 20
46 · median 49
Started
2026
with 3 others
No phase
18 of 28
4 open now
Registered
22nd of 28
by date

Among the 28 studies in Diabetic Neuropathies with a site in Turkey, this one is the 12th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2026, is one of 18 with no phase, and was the 22nd registered.

Diabetic Neuropathies

539 studies on the registry are indexed under Diabetic Neuropathies; 80 are open to participants now.

Browse Diabetic Neuropathies studies →

Open to participants now

6 of the 28 studies in Diabetic Neuropathies with a site in Turkey are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 52 Diabetic Neuropathies studies recruiting now, 21 (40%) set no upper age limit and 24 (46%) stop at 75 or younger; 6 take children under 18; 3 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Diabetic Neuropathies with a site in Turkey, or all of them as a file.
02

Study summary

This prospective observational study aims to evaluate the effects of ultrasound-guided ankle block on sensory and motor block characteristics and postoperative analgesic outcomes in patients undergoing lower extremity surgery. The study will compare diabetic and non-diabetic patients and will also assess the impact of glycemic control on block onset time and postoperative analgesic consumption.

Ankle block is commonly used in patients undergoing foot and ankle surgery, particularly in those with diabetes, peripheral neuropathy, or vascular disease, when general or neuraxial anesthesia may not be suitable. Previous studies suggest that diabetic neuropathy and impaired glycemic control may influence the onset and duration of peripheral nerve blocks.

Adult patients scheduled for lower extremity surgery under ankle block will be included. All procedures will be performed as part of routine clinical care, and no additional interventions will be applied for research purposes. Sensory and motor block onset times, postoperative pain scores, opioid consumption within the first 24 hours, and patient and surgeon satisfaction will be recorded.

The results of this study are expected to provide clinically relevant information regarding the effects of diabetes and glycemic control on ankle block characteristics and postoperative analgesia.

Read the detailed description

Diabetes mellitus is a common chronic metabolic disease, and its increasing prevalence has led to a rise in diabetes-related complications. Diabetic neuropathy is one of the most frequent complications and is associated with structural and functional changes in peripheral nerves, including axonal degeneration and demyelination. These alterations may affect the onset, duration, and quality of peripheral nerve blocks.

Previous clinical and experimental studies have demonstrated that peripheral nerve blocks in patients with diabetic neuropathy may have longer duration and altered onset times compared to non-diabetic patients. Proposed mechanisms include changes in sodium and potassium channel function, delayed clearance of local anesthetics, and reduced microvascular absorption due to diabetic microangiopathy.

Ultrasound-guided ankle block is a commonly used regional anesthesia technique for foot and ankle surgeries, particularly in patients with diabetic foot ulcers, wound debridement, or minor amputations. It provides effective anesthesia and postoperative analgesia while avoiding the potential risks of general or neuraxial anesthesia in high-risk patients.

This study is designed as a single-center, prospective, observational study conducted at Fatih Sultan Mehmet Training and Research Hospital. Adult patients scheduled for lower extremity surgery under ultrasound-guided ankle block between January 2026 and October 2026 will be included after obtaining written informed consent. No additional interventions beyond routine clinical practice will be performed.

The ankle block will be administered preoperatively under ultrasound guidance by an experienced anesthesiologist using a standardized local anesthetic mixture. Sensory and motor block assessments will be performed using pinprick testing and motor function evaluation. Block onset times and block resolution times will be recorded.

Postoperative outcomes will include pain scores assessed using the Visual Analog Scale (VAS), total opioid consumption within the first 24 hours (expressed as morphine equivalents), time to first analgesic request, and the need for rescue analgesia. Patient and surgeon satisfaction will be evaluated using a 10-point numerical rating scale.

Patients will be categorized based on diabetes status and further subgrouped according to glycemic control using HbA1c levels (\<7.5% and ≥7.5%). Outcomes will be compared between diabetic and non-diabetic patients and between glycemic control subgroups to evaluate the effect of diabetes and metabolic control on ankle block characteristics and postoperative analgesic outcomes.

The findings of this study are expected to contribute to a better understanding of regional anesthesia outcomes in diabetic patients and may help optimize anesthetic management strategies in this high-risk population.

03

Conditions studied

  • Diabetes Mellitus
  • Diabetic Neuropathy
  • Postoperative Pain Management

Browse trials for

Keywords

  • Ankle Block
  • Ultrasound-Guided Regional Anesthesia
  • Peripheral Nerve Block
  • Diabetes Mellitus
  • Diabetic Neuropathy
  • Glycemic Control
  • Postoperative Analgesia
  • HBA1C
  • Lower Extremity Surgery
  • Opioid Consumption
04

In context

Diabetic Neuropathies Reclassified

539 studies on the registry are indexed under Diabetic Neuropathies; 80 are open to participants now.

This study's planned enrollment of 46 is below the median of 68 across 449 interventional studies indexed under Diabetic Neuropathies.

Browse Diabetic Neuropathies studies →

Lead sponsor

Fatih Sultan Mehmet Training and Research Hospital is the lead sponsor of 120 studies on the registry; 32 are open to participants now.

Compared within Diabetic Neuropathies, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Diabetes Mellitus. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years and older.
  • Patients scheduled for lower extremity surgery under ultrasound-guided ankle block as part of routine clinical care.
  • Patients able to provide written .
  • Availability of complete perioperative data including blood glucose levels, - values, pain scores, and postoperative analgesic consumption.

Exclusion criteria

Exclusion Criteria:

  • Refusal or inability to provide .
  • Failure of ankle block requiring conversion to another anesthesia technique.
  • Known coagulation disorders contraindicating peripheral nerve block.
  • Active infection at the site of block application.
  • Chronic opioid or analgesic use, chronic alcohol use, or substance abuse.
  • History of diabetic ketoacidosis or hyperosmolar hyperglycemic state.
  • Severe renal or hepatic insufficiency.
  • Known allergy to local anesthetics such as lidocaine or bupivacaine.
  • Inability to perform perioperative blood glucose monitoring.
  • Cognitive impairment or psychiatric conditions interfering with study participation or data collection.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

06

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Observational Cohort

    Adult patients undergoing lower extremity surgery under routine ultrasound-guided ankle block as part of standard clinical care. Participants are not assigned to any intervention for research purposes.

    Procedure: Ultrasound-Guided Ankle Block

Interventions

  • ProcedureUltrasound-Guided Ankle Block

    Ultrasound-guided ankle block performed as part of routine clinical practice for anesthesia and postoperative analgesia. The procedure is not administered as an experimental intervention and is not assigned by the study protocol

07

What researchers measure

Primary outcomes

  1. Sensory Block Onset Time

    Time from completion of ultrasound-guided ankle block to the onset of sensory block, assessed using pinprick testing (score 0: no sensation, 1: reduced sensation, 2: normal sensation).

    Time frame: From block completion up to 30 minutes after block administration

Secondary outcomes

  1. Motor Block Onset Time

    Time from completion of ankle block to onset of motor block, assessed by ankle dorsiflexion and plantarflexion strength, measured in minutes.

    Time frame: From block completion up to 30 minutes after block administration

  2. Total Opioid Consumption in the First 24 Hours

    Total amount of opioid analgesics consumed within the first 24 hours postoperatively, calculated as intravenous morphine equivalents in milligrams.

    Time frame: First 24 hours after surgery

  3. Postoperative Pain Scores

    Postoperative pain intensity assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates worst imaginable pain. Higher scores indicate worse outcome.

    Time frame: At 6, 12, and 24 hours after surgery

08

Study locations

1 site
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Oct 2026, 7 months later.

Of 138 non-industry interventional studies with no phase under Diabetic Neuropathies, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 24. This study's planned 7 months is below that.

Counting every sponsor, half of 153 studies reached it within 11 months; a quarter within 6 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2026
First posted
Feb 11, 2026
StartEst.
Mar 1, 2026
Primary completionEst.
Oct 1, 2026
CompletionEst.
Nov 1, 2026
Last update
Feb 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07404124
Responsible party
dogameric (MD, Anesthesiology Specialist, Fatih Sultan Mehmet Training and Research Hospital) — Principal investigator
First posted
Feb 11, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Feb 11, 2026

Study contacts

DOGA MERİC YUKSELEN, MD
Contact
d.m.boybeyi@gmail.com
+905362963155
doga meric yukselen, MD
principal investigator · ISTANBUL PROVINCIAL HEALTH DIRECTORATE FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion